Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Additionally, PDOs have been widely used for predicting drug sensitivity in CRC and can be combined with mitochondrial function dyes (e.g., JC-1, TMRM) to perform metabolic dependency-based individual screening [178]
38719, document 2026-12937), pushing the deadline to July 30, 2026 As of this article's July 2026 review date, the comment period was still open and FDA had not announced a final determination You can follow the docket directly at either link above rather than relying on this article's summary of it
The policy applies even to used supplements, no matter how many doses remain
Scientific References Non-alcoholic fatty liver disease (NAFLD)
Obesity (Silver Spring) 14 (2), 194198 (2006)
EBioMedicine 39 , 239254 (2019)
